🫶 🫶 Our customers are the reason Weave exists — and the reason we keep raising the bar. Whether they’re leading small but mighty teams in early-stage biotech or driving regulatory execution in later-phase clinical programs, they share one thing: They’re focused on the science

After getting many positive feedback, I decided to write the webinar content as a Substack post: umuteser1.substack.com/p/mastering-th… Audience: non-developers I might write something more technical laying out the emerging best practices across domains that I have seen so far in the future.

💬 𝗪𝗲𝗮𝘃𝗲 𝗪𝗲𝗱𝗻𝗲𝘀𝗱𝗮𝘆 Your words keep us moving forward. Every time we hear how 𝗧𝗵𝗲 𝗪𝗲𝗮𝘃𝗲 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺 saves you hours, catches the details you missed,  or helps regulatory writing feel less like a bottleneck — we listen. And we build. This feedback

Vision: Add a stripe to Adidas → AI still says “three.” Math: Add an irrelevant clause → accuracy drops 65%. Medicine: Replace answer with “None of the above” → collapse. Pattern ≠ reasoning. Post + examples → umuteser1.substack.com/p/the-reasonin…

LLMs can write poetry but can’t count stripes on a shoe. Intelligence needs structure, not scale. I ran an experiment in the most absurd lab: Brainfuck. Multi-scale solutions emerged! Full story 👇 umuteser1.substack.com/p/teaching-ai-… #AI #Emergence #NeuroSymbolic

LLMs aren’t dumb — they’re unstructured. Give GPT-4.1-mini a CoT instruction 10-digit multiplication: ❌ Give GPT-4.1-mini an algorithmic scaffold: ✅ 70–100% accuracy. 👉 Prompting = programming. 👉 Structure unlocks hidden capacity. Full essay here: umuteser1.substack.com/p/prompting-is…

Exciting news! We're thrilled to announce our strategic partnership with Parexel ! Parexel brings deep regulatory consulting expertise that enhances our AI solutions, enabling us to expand The Weave Platform across the entire regulatory lifecycle. Together, we’ve already

It’s now official! Excited to announce that we raised $20m Series A. I can already feel the phase transition from proving the value proposition to scaling and capturing the value creation. So proud of the team Weave Bio !

We’re growing.

⚡ Last week, the FDA took an important step toward transparency. By publishing the same filing checklists CDER reviewers use internally, the FDA is helping sponsors understand what “complete and reviewable” really means. It’s a practical move that could prevent avoidable Refuse

⏱️ When Health Authorities have questions, every hour counts. Meet HAQ Manager, Weave’s new AI-native solution that automates and accelerates Health Authority Question responses — built with Takeda. 🔗 Read more: businesswire.com/news/home/2025… 🎥 Register for the live demo (Nov 14):